Publicaties

VanDerNagel JEL, van Duijvenbode N, Didden R.  2019.  Substance use disorders. Handbook of intellectual disabilities – Integrating theory, research, and practice.

van Duijvenbode N, VanDerNagel JEL.  2019.  A Systematic Review of Substance Use (Disorder) in Individuals with Mild to Borderline Intellectual Disability. Eur Addict Res. :1-20.

van Esch AMJ, Fest A, Hoffland BS, Janzing JGE, Steens SCA, Esselink RAJ, Schellekens AFA.  2019.  Toxic Leukoencephalopathy Presenting as Lethal Catatonia. J Addict Med. 13(3):241-244.

Beurmanjer H, Kamal RM, de Jong CAJ, Dijkstra BAG, Schellekens AFA.  2018.  Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial.. CNS Drugs. 32(5):437-442.

Leskauskas D, Adomaitienė V, De Jong CAJ, Vorevičiūtė B, Juknaitė R.  2018.  Changes over time in Lithuanian schoolchildren's attitudes toward addictive behaviors: Promoting and preventing factors.. PLoS One. 13(12):e0208481.

Duijvenbode vanN, Didden R, VanDerNagel JEL, Korzilius HPLM, Engels RCME.  2018.  Cognitive deficits in problematic drinkers with and without mild to borderline intellectual disability. Journal of Intellectual Disabilities. 22(1):5-17.

van Erp N, Verbrugge C.  2018.  Factsheet Herstel en Verslaving. Verslavingskunde Nederland GGZ1830-01.

van Elsué N, Crunelle C, Verbrugge C, van Baarle K, Rodriquez A, Neels H, Yegles M.  2018.  Gammahydroxybutyrate in hair of non-GHB and repeated GHB users: A new and optimized method.. Forensic Science International.

Soe-Agnie SE, Paap MCS, VanDerNagel JEL, Nijman HJM, de Jong CAJ.  2018.  The generalizability of the structure of substance abuse and antisocial behavioral syndromes: A systematic review. Psychiatry Research. 259:412-421.

Soe-Agnie SE, Paap MCS, VanDerNagel JEL, Nijman HJM, de Jong CAJ.  2018.  The generalizability of the structure of substance abuse and antisocial behavioral syndromes: A systematic review.. Psychiatry Res. 259:412-421.

Knuijver T, Belgers M, Markus W, Verkes R-J, van Oosteren T, Schellekens AFA.  2018.  Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence. J Clin Psychopharmacol. 38(6):646-648.

Verbrugge C, Stollenga M, Hollander.T den, Dijkstra B.  2018.  Herstelsteun. Toepassingen in praktijk van de verslavingszorg.Ingediend.. Handboek Steunend Relationeel Handelen.

VanDerNagel JEL, Duijvenbode vanN, Ruedrich S., Ayu A.P., Schellekens A.F.A..  2018.  The Perception of Substance Use Disorder Among Clinicians, Caregivers and Family Members of Individuals With Intellectual and Developmental Disabilities. Journal of mental health research in intellectual disabilities. 11:54-68.

Duijvenbode vanN, Didden R, VanDerNagel JEL, Korzilius HPLM, Engels RCME.  2018.  The relationship between drinking motives and interpretation bias in problematic drinkers with mild to borderline intellectual disability. Journal of Intellectual & Developmental Disability. 43(2):125-136.

Kraan AEM, Dijkstra BAG, Markus W.  2018.  Treatment delivery of the community reinforcement approach in outpatient addiction treatment.. Eval Program Plann. 70:61-66.

De Weert GH, Markus W, Kissane DW, DeJong CA.  2017.  Demoralization in Patients With Substance Use and Co-Occurring Psychiatric Disorders.. J Dual Diagn. 13(2):136-143.

de Weert-van Oene GH, Markus W, Kissane DW, DeJong CA.  2017.  Demoralization in patients with substance use and co-occurring psychiatric disorders. . Journal of Dual Diagnosis. 13(2)

Martial LC, Aarnoutse RE, Mulder M, Schellekens A, Brüggemann RJM, Burger DM, Schene AH, Batalla A.  2017.  Dried Blood Spot sampling in psychiatry: Perspectives for improving therapeutic drug monitoring.. Eur Neuropsychopharmacol. 27(3):205-216.

Kiewik M, VanDerNagel JEl, Engels RCME, DeJong CA.  2017.  The efficacy of an e-learning prevention program for substance use among adolescents with intellectual disabilities: A pilot study.. Res Dev Disabil. 63:160-166.

Markus W, Hornsveld H.  2017.  EMDR interventions in addiction.. Journal of EMDR Practice and Research. 11(1):27.

Qurishi R., Markus W, Habra M.J.M., Bressers B., DeJong CA.  2017.  EMDR therapy reduces intense treatment-resistant cravings in a case of gamma-Hydroxybutyric acid addiction. Journal of EMDR Practice and Research. 11(1)

Markus W, Geurink M., S. Gi TPian, De Jongh A., Kranenburg L..  2017.   Eye Movement Desensitization and Reprocessing (EMDR) therapie.. Databank(en): Langdurige GGZ..

Verbrugge CAG, Stollenga M..  2017.  Herstelondersteuning in Nederland: een stand van zaken. Naar een herstelondersteunende verslavingszorg. :18.

de Jong MArts-, DeJong CA, Hermens RP, Kissane DW, Massuger LM, Hoogerbrugge N, Prins JB, deHullu JA.  2017.  High demoralization in a minority of oophorectomized BRCA1/2 mutation carriers influences quality of life.. J Psychosom Obstet Gynaecol. :1-9.

van Lier H.G., Pieterse M.E., Schraagen J.M.C., Postel M.G., Vollenbroek-Hutten M.M.R., de Haan H.A., Noordzij M.L..  2017.  Identifying viable theoretical frameworks with essential parameters for real-time and real world alcohol craving research: a systematic review of craving models. . Addiction Research & Theory.